Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Other-Non-Cash-Items" stands at 123.01 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.
Astellas Pharma Inc.'s second quarter result of 16.28 Billion JPY for the item "Other Non Cash Items" represents an increase of 223.28 percent compared to it's first quarter result.
Also, Astellas Pharma Inc.'s second quarter result of 16.28 Billion JPY for the item "Other Non Cash Items" represents an increase of 461.38 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Astellas Pharma Inc.'s second quarter result of 123.01 Billion JPY for the item "Other Non Cash Items" represents an increase of 20.33 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 121.86 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 121.86 Billion Japanese Yens.
The 3 year change is 135.06 Billion Japanese Yens.
The 5 year change is 88.13 Billion Japanese Yens.
The 10 year change is 198.73 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Non Cash Items | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Non Cash Items | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Non Cash Items | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Non Cash Items | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Non Cash Items | 280,205,508,085.11 |